Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging | 88 | 2023 | 35421 | 1.060 |
Why?
|
Brain Mapping | 29 | 2021 | 6669 | 0.790 |
Why?
|
Schizophrenia | 18 | 2022 | 6882 | 0.690 |
Why?
|
Brain | 45 | 2023 | 26385 | 0.610 |
Why?
|
Acupuncture Analgesia | 6 | 2021 | 62 | 0.600 |
Why?
|
Acupuncture Therapy | 6 | 2023 | 464 | 0.580 |
Why?
|
Diffusion Magnetic Resonance Imaging | 19 | 2021 | 2737 | 0.560 |
Why?
|
Positron-Emission Tomography | 14 | 2022 | 6234 | 0.540 |
Why?
|
Cerebellar Diseases | 4 | 2021 | 226 | 0.490 |
Why?
|
Prefrontal Cortex | 6 | 2021 | 2147 | 0.490 |
Why?
|
Pain Threshold | 7 | 2021 | 584 | 0.460 |
Why?
|
Image Processing, Computer-Assisted | 18 | 2020 | 8949 | 0.440 |
Why?
|
Placebo Effect | 9 | 2021 | 502 | 0.400 |
Why?
|
Prostatic Neoplasms | 12 | 2024 | 11124 | 0.390 |
Why?
|
Neurologic Examination | 4 | 2018 | 930 | 0.380 |
Why?
|
Fear | 5 | 2023 | 1440 | 0.370 |
Why?
|
Neural Pathways | 13 | 2021 | 2972 | 0.370 |
Why?
|
Saccades | 7 | 2014 | 246 | 0.350 |
Why?
|
Psychomotor Performance | 6 | 2024 | 1901 | 0.340 |
Why?
|
Ataxia | 2 | 2022 | 304 | 0.340 |
Why?
|
Pain | 13 | 2021 | 4986 | 0.330 |
Why?
|
Male | 138 | 2024 | 350118 | 0.320 |
Why?
|
Cerebral Cortex | 11 | 2019 | 5708 | 0.320 |
Why?
|
Sleep | 10 | 2024 | 4623 | 0.320 |
Why?
|
Memory, Short-Term | 2 | 2011 | 975 | 0.310 |
Why?
|
Abdominal Neoplasms | 2 | 2021 | 292 | 0.310 |
Why?
|
Electroacupuncture | 4 | 2011 | 60 | 0.310 |
Why?
|
Prostate | 5 | 2019 | 1774 | 0.300 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 2 | 2021 | 161 | 0.290 |
Why?
|
Cerebellum | 3 | 2015 | 1488 | 0.290 |
Why?
|
Acupuncture Points | 5 | 2013 | 101 | 0.280 |
Why?
|
Humans | 174 | 2024 | 744343 | 0.270 |
Why?
|
Diffusion Tensor Imaging | 11 | 2022 | 2305 | 0.270 |
Why?
|
Magnetoencephalography | 6 | 2014 | 623 | 0.270 |
Why?
|
Vagus Nerve Stimulation | 2 | 2021 | 199 | 0.270 |
Why?
|
Nerve Fibers, Myelinated | 5 | 2018 | 957 | 0.270 |
Why?
|
Adult | 96 | 2024 | 214055 | 0.270 |
Why?
|
Movement Disorders | 1 | 2009 | 445 | 0.270 |
Why?
|
Female | 122 | 2022 | 380194 | 0.260 |
Why?
|
Middle Aged | 86 | 2022 | 213383 | 0.260 |
Why?
|
Brain Infarction | 4 | 2011 | 299 | 0.260 |
Why?
|
Disability Evaluation | 2 | 2009 | 1827 | 0.260 |
Why?
|
Hyperalgesia | 3 | 2021 | 502 | 0.250 |
Why?
|
Fluorodeoxyglucose F18 | 9 | 2022 | 2016 | 0.250 |
Why?
|
Algorithms | 10 | 2019 | 13881 | 0.250 |
Why?
|
Functional Laterality | 8 | 2019 | 2290 | 0.250 |
Why?
|
Stroke | 10 | 2017 | 9981 | 0.240 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2017 | 182 | 0.240 |
Why?
|
Gadolinium DTPA | 6 | 2019 | 836 | 0.230 |
Why?
|
Image Interpretation, Computer-Assisted | 11 | 2016 | 3327 | 0.230 |
Why?
|
Huntington Disease | 4 | 2018 | 1124 | 0.230 |
Why?
|
Analysis of Variance | 8 | 2021 | 6365 | 0.220 |
Why?
|
Gyrus Cinguli | 8 | 2019 | 1091 | 0.220 |
Why?
|
Frontal Lobe | 6 | 2015 | 1406 | 0.220 |
Why?
|
Somatosensory Cortex | 4 | 2011 | 528 | 0.220 |
Why?
|
Neck Pain | 1 | 2023 | 180 | 0.210 |
Why?
|
Cognition Disorders | 4 | 2022 | 4043 | 0.210 |
Why?
|
Contrast Media | 11 | 2019 | 5300 | 0.210 |
Why?
|
Young Adult | 34 | 2023 | 56430 | 0.200 |
Why?
|
Pain Perception | 2 | 2014 | 191 | 0.200 |
Why?
|
Mental Recall | 3 | 2023 | 1205 | 0.200 |
Why?
|
Severity of Illness Index | 7 | 2018 | 15540 | 0.200 |
Why?
|
Anisotropy | 7 | 2022 | 1265 | 0.200 |
Why?
|
Pain Measurement | 11 | 2015 | 3420 | 0.200 |
Why?
|
Hippocampus | 6 | 2024 | 3675 | 0.200 |
Why?
|
Nerve Net | 7 | 2014 | 2174 | 0.200 |
Why?
|
Inositol | 1 | 2021 | 218 | 0.190 |
Why?
|
Pressure Ulcer | 1 | 2022 | 155 | 0.190 |
Why?
|
Language | 2 | 2021 | 1471 | 0.190 |
Why?
|
Evoked Potentials | 3 | 2014 | 1056 | 0.190 |
Why?
|
Extinction, Psychological | 2 | 2023 | 376 | 0.180 |
Why?
|
Consumer Product Safety | 1 | 2020 | 122 | 0.180 |
Why?
|
Aged | 53 | 2021 | 163280 | 0.180 |
Why?
|
Reproducibility of Results | 19 | 2019 | 19905 | 0.170 |
Why?
|
Polysomnography | 4 | 2019 | 1776 | 0.170 |
Why?
|
Rest | 5 | 2016 | 901 | 0.170 |
Why?
|
Cognition | 9 | 2022 | 6770 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1101 | 0.170 |
Why?
|
Sensitivity and Specificity | 14 | 2022 | 14722 | 0.170 |
Why?
|
Generalization, Response | 1 | 2018 | 8 | 0.170 |
Why?
|
Conditioning, Classical | 2 | 2019 | 366 | 0.170 |
Why?
|
Vascular System Injuries | 1 | 2022 | 250 | 0.170 |
Why?
|
Cerebral Infarction | 5 | 2008 | 1011 | 0.170 |
Why?
|
Brain Ischemia | 5 | 2017 | 3265 | 0.160 |
Why?
|
Whole Body Imaging | 2 | 2020 | 280 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 9 | 2021 | 20129 | 0.160 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 570 | 0.160 |
Why?
|
Verbal Behavior | 1 | 2020 | 339 | 0.160 |
Why?
|
Acupuncture | 2 | 2010 | 90 | 0.160 |
Why?
|
Galvanic Skin Response | 2 | 2018 | 349 | 0.160 |
Why?
|
Oxytocin | 1 | 2022 | 394 | 0.160 |
Why?
|
Corneal Ulcer | 1 | 2019 | 169 | 0.160 |
Why?
|
Qi | 2 | 2007 | 15 | 0.160 |
Why?
|
Social Perception | 2 | 2016 | 425 | 0.160 |
Why?
|
Brain Neoplasms | 4 | 2021 | 8863 | 0.160 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11031 | 0.160 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5256 | 0.160 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 4644 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3760 | 0.160 |
Why?
|
Motor Skills | 4 | 2024 | 522 | 0.150 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 71 | 0.150 |
Why?
|
Myelin Sheath | 2 | 2021 | 652 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 337 | 0.150 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2021 | 638 | 0.150 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2016 | 475 | 0.150 |
Why?
|
Retrospective Studies | 30 | 2022 | 77449 | 0.150 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1377 | 0.150 |
Why?
|
Reaction Time | 9 | 2013 | 2097 | 0.150 |
Why?
|
Pattern Recognition, Automated | 2 | 2016 | 1005 | 0.150 |
Why?
|
Placental Insufficiency | 1 | 2017 | 51 | 0.150 |
Why?
|
Oxygen | 5 | 2017 | 4189 | 0.150 |
Why?
|
Sex Characteristics | 3 | 2021 | 2585 | 0.150 |
Why?
|
Electroencephalography | 7 | 2023 | 6150 | 0.150 |
Why?
|
Eye Infections, Bacterial | 1 | 2019 | 235 | 0.140 |
Why?
|
Cerebral Arterial Diseases | 1 | 2017 | 82 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 241 | 0.140 |
Why?
|
Sensation | 2 | 2009 | 336 | 0.140 |
Why?
|
Analgesia | 1 | 2021 | 461 | 0.140 |
Why?
|
Intubation, Intratracheal | 2 | 2022 | 1364 | 0.140 |
Why?
|
Foreign Bodies | 1 | 2020 | 399 | 0.140 |
Why?
|
Voice Disorders | 1 | 2020 | 276 | 0.140 |
Why?
|
Cross-Over Studies | 6 | 2021 | 2029 | 0.140 |
Why?
|
Government Regulation | 1 | 2020 | 522 | 0.140 |
Why?
|
Caffeine | 1 | 2021 | 699 | 0.140 |
Why?
|
Hot Temperature | 5 | 2015 | 1354 | 0.140 |
Why?
|
Ear Auricle | 1 | 2016 | 32 | 0.140 |
Why?
|
Mitotic Index | 1 | 2016 | 172 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 665 | 0.130 |
Why?
|
Radiopharmaceuticals | 7 | 2022 | 2645 | 0.130 |
Why?
|
Likelihood Functions | 1 | 1999 | 1005 | 0.130 |
Why?
|
Osteoarthritis, Knee | 2 | 2016 | 1222 | 0.130 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6773 | 0.130 |
Why?
|
Corneal Diseases | 1 | 2022 | 636 | 0.130 |
Why?
|
Aged, 80 and over | 24 | 2020 | 57776 | 0.130 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2015 | 62 | 0.130 |
Why?
|
Pilot Projects | 7 | 2024 | 8324 | 0.130 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2529 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2020 | 569 | 0.130 |
Why?
|
Nerve Degeneration | 2 | 2018 | 748 | 0.120 |
Why?
|
Synovitis | 1 | 2016 | 209 | 0.120 |
Why?
|
Temporomandibular Joint | 1 | 2016 | 196 | 0.120 |
Why?
|
Bipolar Disorder | 1 | 2011 | 5027 | 0.120 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 567 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2018 | 3589 | 0.120 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 516 | 0.120 |
Why?
|
Video Recording | 1 | 2019 | 949 | 0.120 |
Why?
|
Radiology Information Systems | 1 | 2019 | 523 | 0.120 |
Why?
|
Executive Function | 3 | 2018 | 1364 | 0.120 |
Why?
|
Predictive Value of Tests | 11 | 2021 | 15076 | 0.120 |
Why?
|
Neuropsychological Tests | 8 | 2018 | 6993 | 0.120 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2014 | 284 | 0.110 |
Why?
|
Axons | 2 | 2021 | 1684 | 0.110 |
Why?
|
Cerebrovascular Circulation | 3 | 2015 | 2731 | 0.110 |
Why?
|
Postpartum Period | 1 | 2020 | 1086 | 0.110 |
Why?
|
Thalamus | 1 | 2019 | 1023 | 0.110 |
Why?
|
Parietal Lobe | 5 | 2015 | 838 | 0.110 |
Why?
|
Motion Sickness | 1 | 2013 | 35 | 0.110 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2728 | 0.110 |
Why?
|
Simian immunodeficiency virus | 1 | 2018 | 846 | 0.110 |
Why?
|
Cryosurgery | 1 | 2017 | 453 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
Glaucoma | 1 | 2022 | 1159 | 0.110 |
Why?
|
Models, Neurological | 2 | 2012 | 1774 | 0.110 |
Why?
|
HIV | 1 | 2020 | 1604 | 0.110 |
Why?
|
Spinocerebellar Ataxias | 1 | 2013 | 91 | 0.100 |
Why?
|
Catechol O-Methyltransferase | 1 | 2014 | 245 | 0.100 |
Why?
|
Connective Tissue | 1 | 2014 | 420 | 0.100 |
Why?
|
Acupressure | 1 | 2011 | 16 | 0.100 |
Why?
|
Prospective Studies | 16 | 2024 | 53288 | 0.100 |
Why?
|
Image Enhancement | 4 | 2016 | 2921 | 0.100 |
Why?
|
Panic Disorder | 1 | 2015 | 616 | 0.100 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2002 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 544 | 0.100 |
Why?
|
Regression Analysis | 7 | 2020 | 6459 | 0.100 |
Why?
|
Sleep Stages | 2 | 2020 | 686 | 0.100 |
Why?
|
Child of Impaired Parents | 1 | 2015 | 455 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 1 | 2021 | 2038 | 0.100 |
Why?
|
Adolescent | 20 | 2022 | 85781 | 0.100 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2017 | 531 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1206 | 0.100 |
Why?
|
Self Report | 2 | 2020 | 3558 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1634 | 0.100 |
Why?
|
Hormone Antagonists | 1 | 2011 | 108 | 0.100 |
Why?
|
Ischemic Attack, Transient | 2 | 2008 | 935 | 0.100 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 243 | 0.100 |
Why?
|
Prostatic Hyperplasia | 1 | 2015 | 523 | 0.100 |
Why?
|
Orbit | 1 | 2014 | 426 | 0.100 |
Why?
|
Learning | 2 | 2014 | 1713 | 0.090 |
Why?
|
Preoperative Care | 1 | 2020 | 2250 | 0.090 |
Why?
|
Microcirculation | 1 | 2015 | 1286 | 0.090 |
Why?
|
Mastectomy, Segmental | 1 | 2016 | 956 | 0.090 |
Why?
|
Fibromyalgia | 1 | 2015 | 388 | 0.090 |
Why?
|
Mifepristone | 1 | 2011 | 150 | 0.090 |
Why?
|
Paresis | 1 | 2011 | 179 | 0.090 |
Why?
|
Pyramidal Tracts | 2 | 2009 | 256 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.090 |
Why?
|
Longitudinal Studies | 8 | 2021 | 13989 | 0.090 |
Why?
|
Personality | 1 | 2014 | 552 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2025 | 0.090 |
Why?
|
Amygdala | 2 | 2009 | 1315 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1095 | 0.090 |
Why?
|
Intention | 1 | 2013 | 341 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7659 | 0.090 |
Why?
|
Leukoaraiosis | 1 | 2011 | 120 | 0.090 |
Why?
|
Neuroendocrine Tumors | 1 | 2016 | 594 | 0.090 |
Why?
|
Cues | 2 | 2013 | 873 | 0.090 |
Why?
|
Nausea | 1 | 2013 | 673 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2015 | 721 | 0.090 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1970 | 0.090 |
Why?
|
Seasonal Affective Disorder | 1 | 2009 | 50 | 0.090 |
Why?
|
Propranolol | 1 | 2011 | 502 | 0.090 |
Why?
|
RNA, Viral | 1 | 2018 | 2902 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3022 | 0.090 |
Why?
|
Double-Blind Method | 5 | 2023 | 12026 | 0.090 |
Why?
|
Prostatectomy | 4 | 2019 | 1890 | 0.090 |
Why?
|
Neuroglia | 1 | 2015 | 927 | 0.090 |
Why?
|
Anxiety | 4 | 2020 | 4297 | 0.090 |
Why?
|
Reperfusion Injury | 1 | 2016 | 1026 | 0.080 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2018 | 2232 | 0.080 |
Why?
|
Linear Models | 3 | 2020 | 5952 | 0.080 |
Why?
|
Time Factors | 13 | 2018 | 40075 | 0.080 |
Why?
|
Infant Behavior | 1 | 2010 | 156 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2017 | 20822 | 0.080 |
Why?
|
Single-Blind Method | 3 | 2021 | 1590 | 0.080 |
Why?
|
Cost of Illness | 1 | 2018 | 1859 | 0.080 |
Why?
|
Artifacts | 2 | 2015 | 1904 | 0.080 |
Why?
|
Photic Stimulation | 5 | 2015 | 2025 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2703 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1715 | 0.080 |
Why?
|
Carbonated Beverages | 1 | 2009 | 214 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3046 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.080 |
Why?
|
Lung Neoplasms | 5 | 2021 | 13102 | 0.080 |
Why?
|
Standard of Care | 2 | 2022 | 564 | 0.080 |
Why?
|
Temperament | 1 | 2010 | 283 | 0.080 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 550 | 0.080 |
Why?
|
Meditation | 1 | 2010 | 242 | 0.080 |
Why?
|
Corpus Callosum | 2 | 2009 | 737 | 0.080 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2007 | 98 | 0.070 |
Why?
|
Organ Size | 3 | 2017 | 2252 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2268 | 0.070 |
Why?
|
Laboratories | 2 | 2003 | 463 | 0.070 |
Why?
|
Memory | 3 | 2024 | 2174 | 0.070 |
Why?
|
Coma | 1 | 2011 | 475 | 0.070 |
Why?
|
Motor Cortex | 1 | 2014 | 986 | 0.070 |
Why?
|
Obesity | 2 | 2022 | 12745 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2017 | 5317 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3481 | 0.070 |
Why?
|
Ultrasonography | 2 | 2017 | 5985 | 0.070 |
Why?
|
Prognosis | 12 | 2017 | 29063 | 0.070 |
Why?
|
Neuralgia | 1 | 2012 | 570 | 0.070 |
Why?
|
Basal Ganglia | 2 | 2006 | 546 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1018 | 0.070 |
Why?
|
Rectum | 1 | 2010 | 904 | 0.070 |
Why?
|
Aging | 4 | 2021 | 8664 | 0.070 |
Why?
|
Dominance, Cerebral | 1 | 2007 | 635 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2018 | 2245 | 0.070 |
Why?
|
Histones | 1 | 2016 | 2599 | 0.070 |
Why?
|
Anticoagulants | 1 | 2021 | 4599 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 1240 | 0.070 |
Why?
|
Orientation | 1 | 2007 | 327 | 0.070 |
Why?
|
Neuronal Plasticity | 2 | 2011 | 1422 | 0.070 |
Why?
|
Vision, Ocular | 1 | 2009 | 464 | 0.070 |
Why?
|
Biopsy | 2 | 2015 | 6756 | 0.070 |
Why?
|
Macaca mulatta | 2 | 2018 | 2375 | 0.060 |
Why?
|
Choline O-Acetyltransferase | 1 | 2005 | 150 | 0.060 |
Why?
|
Organometallic Compounds | 1 | 2009 | 665 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3508 | 0.060 |
Why?
|
Irritable Bowel Syndrome | 1 | 2010 | 445 | 0.060 |
Why?
|
Stem Cell Transplantation | 2 | 2004 | 1620 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2018 | 6038 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2004 | 5221 | 0.060 |
Why?
|
Needles | 1 | 2007 | 449 | 0.060 |
Why?
|
Food | 1 | 2009 | 771 | 0.060 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2007 | 367 | 0.060 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 906 | 0.060 |
Why?
|
Models, Biological | 3 | 2016 | 9583 | 0.060 |
Why?
|
Ki-67 Antigen | 2 | 2017 | 644 | 0.060 |
Why?
|
Motor Activity | 1 | 2014 | 2714 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4256 | 0.060 |
Why?
|
Brain Concussion | 1 | 2015 | 1320 | 0.060 |
Why?
|
Peripheral Nerves | 1 | 2007 | 466 | 0.060 |
Why?
|
Reference Values | 4 | 2021 | 4982 | 0.060 |
Why?
|
Gait | 1 | 2009 | 793 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2758 | 0.060 |
Why?
|
Emotions | 2 | 2019 | 2661 | 0.060 |
Why?
|
Case-Control Studies | 8 | 2020 | 21746 | 0.060 |
Why?
|
Placebos | 3 | 2019 | 1676 | 0.060 |
Why?
|
Psychophysics | 3 | 2012 | 309 | 0.060 |
Why?
|
Oligopeptides | 1 | 2009 | 1189 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2016 | 1972 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 1677 | 0.060 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2007 | 300 | 0.060 |
Why?
|
Observer Variation | 4 | 2016 | 2593 | 0.060 |
Why?
|
Age Factors | 5 | 2015 | 18370 | 0.060 |
Why?
|
Sympathetic Nervous System | 1 | 2006 | 514 | 0.060 |
Why?
|
Statistics as Topic | 3 | 2016 | 2373 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6364 | 0.060 |
Why?
|
Fingers | 3 | 2014 | 513 | 0.060 |
Why?
|
Treatment Outcome | 12 | 2022 | 63114 | 0.050 |
Why?
|
Motion | 2 | 2018 | 798 | 0.050 |
Why?
|
Schizophrenic Psychology | 2 | 2011 | 1678 | 0.050 |
Why?
|
Visual Perception | 2 | 2018 | 1420 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2009 | 834 | 0.050 |
Why?
|
Crohn Disease | 1 | 2015 | 2303 | 0.050 |
Why?
|
Anger | 1 | 2005 | 402 | 0.050 |
Why?
|
Perception | 1 | 2009 | 1198 | 0.050 |
Why?
|
Occipital Lobe | 1 | 2004 | 379 | 0.050 |
Why?
|
Child | 10 | 2022 | 77709 | 0.050 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2005 | 222 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39050 | 0.050 |
Why?
|
Cohort Studies | 8 | 2021 | 40561 | 0.050 |
Why?
|
Tumor Burden | 2 | 2020 | 1915 | 0.050 |
Why?
|
Cadmium | 1 | 2023 | 212 | 0.050 |
Why?
|
Problem Solving | 1 | 2004 | 440 | 0.050 |
Why?
|
Amnesia | 1 | 2024 | 248 | 0.050 |
Why?
|
Acute Disease | 4 | 2016 | 7149 | 0.050 |
Why?
|
Culture | 1 | 2006 | 633 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4253 | 0.050 |
Why?
|
Colombia | 1 | 2022 | 258 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7181 | 0.050 |
Why?
|
Attention | 2 | 2016 | 2400 | 0.050 |
Why?
|
Endocarditis | 1 | 2005 | 350 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2022 | 446 | 0.050 |
Why?
|
Recovery of Function | 1 | 2011 | 2925 | 0.050 |
Why?
|
Hypothalamus | 1 | 2007 | 1063 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2007 | 824 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9338 | 0.050 |
Why?
|
Troponin T | 1 | 2006 | 754 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.050 |
Why?
|
Arterial Occlusive Diseases | 1 | 2005 | 793 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3445 | 0.050 |
Why?
|
Heart Arrest | 1 | 2011 | 1470 | 0.050 |
Why?
|
Genotype | 4 | 2020 | 12951 | 0.050 |
Why?
|
Interneurons | 1 | 2005 | 577 | 0.050 |
Why?
|
Visual Cortex | 1 | 2009 | 1149 | 0.050 |
Why?
|
Collagen | 1 | 2009 | 2689 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 3 | 2010 | 4042 | 0.050 |
Why?
|
Thoracic Surgical Procedures | 1 | 2004 | 342 | 0.050 |
Why?
|
Eye Evisceration | 1 | 2019 | 23 | 0.050 |
Why?
|
Kidney | 1 | 2016 | 7186 | 0.050 |
Why?
|
Equipment Failure | 1 | 2022 | 578 | 0.050 |
Why?
|
Prostate-Specific Antigen | 2 | 2024 | 2494 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2009 | 2418 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4462 | 0.040 |
Why?
|
Eye Enucleation | 1 | 2019 | 128 | 0.040 |
Why?
|
Phenotype | 5 | 2020 | 16365 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2022 | 395 | 0.040 |
Why?
|
Corneal Perforation | 1 | 2019 | 32 | 0.040 |
Why?
|
Cerebral Angiography | 1 | 2005 | 1285 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5034 | 0.040 |
Why?
|
Neurofibroma | 1 | 2020 | 106 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2003 | 651 | 0.040 |
Why?
|
Early Diagnosis | 3 | 2011 | 1184 | 0.040 |
Why?
|
Japan | 1 | 2023 | 1360 | 0.040 |
Why?
|
Acoustic Stimulation | 1 | 2023 | 1216 | 0.040 |
Why?
|
Glioma | 1 | 2014 | 3401 | 0.040 |
Why?
|
Keratoplasty, Penetrating | 1 | 2019 | 155 | 0.040 |
Why?
|
Vagus Nerve | 1 | 2021 | 438 | 0.040 |
Why?
|
Melatonin | 1 | 2005 | 721 | 0.040 |
Why?
|
Transplantation, Homologous | 2 | 2004 | 4776 | 0.040 |
Why?
|
Disease Progression | 5 | 2017 | 13284 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2005 | 1261 | 0.040 |
Why?
|
Liposomes | 1 | 2022 | 759 | 0.040 |
Why?
|
Citalopram | 1 | 2021 | 403 | 0.040 |
Why?
|
Survival Rate | 4 | 2021 | 12788 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10262 | 0.040 |
Why?
|
Phonation | 1 | 2020 | 219 | 0.040 |
Why?
|
Limbic System | 1 | 2021 | 426 | 0.040 |
Why?
|
Face | 1 | 2004 | 994 | 0.040 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2647 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3679 | 0.040 |
Why?
|
Airway Management | 1 | 2021 | 329 | 0.040 |
Why?
|
United States | 6 | 2022 | 69872 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9239 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 711 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2022 | 642 | 0.040 |
Why?
|
Minocycline | 1 | 2018 | 163 | 0.040 |
Why?
|
Endophthalmitis | 1 | 2019 | 262 | 0.040 |
Why?
|
Incidence | 4 | 2020 | 20947 | 0.040 |
Why?
|
Myocardium | 2 | 2009 | 4776 | 0.040 |
Why?
|
Animals | 10 | 2022 | 168757 | 0.040 |
Why?
|
Brain Diseases | 1 | 2006 | 1563 | 0.040 |
Why?
|
Temporal Lobe | 1 | 2004 | 1670 | 0.040 |
Why?
|
Random Allocation | 1 | 2021 | 2429 | 0.040 |
Why?
|
Hematoxylin | 1 | 2016 | 64 | 0.030 |
Why?
|
Voice | 1 | 2020 | 259 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2016 | 72 | 0.030 |
Why?
|
Androgens | 1 | 2024 | 1281 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2765 | 0.030 |
Why?
|
Corpus Striatum | 2 | 2014 | 1221 | 0.030 |
Why?
|
Energy Metabolism | 2 | 2007 | 2899 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25043 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18029 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1656 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2005 | 1004 | 0.030 |
Why?
|
Oxygen Consumption | 2 | 2015 | 1869 | 0.030 |
Why?
|
Biometry | 1 | 1999 | 558 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2003 | 1061 | 0.030 |
Why?
|
Emotional Intelligence | 1 | 2016 | 136 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2005 | 2158 | 0.030 |
Why?
|
Verbal Learning | 1 | 2018 | 467 | 0.030 |
Why?
|
Microbubbles | 1 | 2016 | 128 | 0.030 |
Why?
|
Physical Stimulation | 2 | 2008 | 525 | 0.030 |
Why?
|
Vocal Cords | 1 | 2020 | 528 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2924 | 0.030 |
Why?
|
Hyperoxia | 1 | 2017 | 262 | 0.030 |
Why?
|
Self Administration | 1 | 2016 | 385 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1584 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2004 | 1185 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12354 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1387 | 0.030 |
Why?
|
Skin | 2 | 2023 | 4364 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2021 | 981 | 0.030 |
Why?
|
Ependyma | 1 | 2014 | 54 | 0.030 |
Why?
|
South Africa | 1 | 2020 | 1731 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2715 | 0.030 |
Why?
|
Personality Tests | 1 | 2014 | 83 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6538 | 0.030 |
Why?
|
Head Injuries, Closed | 1 | 2015 | 136 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 383 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 72290 | 0.030 |
Why?
|
Child, Preschool | 5 | 2020 | 41006 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2006 | 1912 | 0.030 |
Why?
|
ROC Curve | 2 | 2016 | 3527 | 0.030 |
Why?
|
Length of Stay | 2 | 2017 | 6309 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2004 | 1770 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1877 | 0.030 |
Why?
|
Receptors, Dopamine D4 | 1 | 2014 | 171 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2015 | 915 | 0.030 |
Why?
|
Arteries | 1 | 2018 | 1119 | 0.030 |
Why?
|
Coloring Agents | 1 | 2016 | 566 | 0.030 |
Why?
|
Maze Learning | 1 | 2015 | 478 | 0.030 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2013 | 37 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15226 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6196 | 0.030 |
Why?
|
Causality | 2 | 2011 | 1275 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16718 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 10900 | 0.030 |
Why?
|
Perineum | 1 | 2014 | 211 | 0.030 |
Why?
|
Cystectomy | 1 | 2018 | 686 | 0.030 |
Why?
|
Confidence Intervals | 1 | 1999 | 2971 | 0.030 |
Why?
|
Receptors, GABA | 1 | 2015 | 288 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2016 | 5078 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10388 | 0.030 |
Why?
|
Biological Clocks | 1 | 2015 | 321 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2016 | 1901 | 0.030 |
Why?
|
Optic Nerve | 1 | 2016 | 554 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2004 | 1832 | 0.030 |
Why?
|
Research Design | 1 | 2008 | 5987 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1097 | 0.030 |
Why?
|
Diagnosis | 1 | 2013 | 154 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1106 | 0.030 |
Why?
|
Empathy | 1 | 2016 | 474 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1788 | 0.030 |
Why?
|
Abdomen | 1 | 2018 | 1118 | 0.030 |
Why?
|
Trinucleotide Repeats | 1 | 2013 | 261 | 0.030 |
Why?
|
Infant | 4 | 2020 | 35136 | 0.030 |
Why?
|
Chronic Disease | 3 | 2015 | 9146 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1107 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 2017 | 2416 | 0.030 |
Why?
|
Freezing Reaction, Cataleptic | 1 | 2011 | 42 | 0.030 |
Why?
|
Longevity | 1 | 2019 | 1070 | 0.030 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 816 | 0.020 |
Why?
|
Models, Statistical | 3 | 2016 | 5102 | 0.020 |
Why?
|
Alleles | 2 | 2014 | 6933 | 0.020 |
Why?
|
Electroretinography | 1 | 2013 | 509 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4149 | 0.020 |
Why?
|
Spin Labels | 1 | 2012 | 332 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2886 | 0.020 |
Why?
|
Echo-Planar Imaging | 2 | 2006 | 659 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2622 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2004 | 11524 | 0.020 |
Why?
|
Memory, Long-Term | 1 | 2011 | 64 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3778 | 0.020 |
Why?
|
Feedback, Psychological | 1 | 2011 | 97 | 0.020 |
Why?
|
Bayes Theorem | 1 | 1999 | 2309 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2386 | 0.020 |
Why?
|
Atrophy | 2 | 2006 | 1583 | 0.020 |
Why?
|
Strabismus | 1 | 2014 | 287 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2013 | 365 | 0.020 |
Why?
|
Brain Waves | 1 | 2014 | 401 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2012 | 502 | 0.020 |
Why?
|
Acetaminophen | 1 | 2013 | 545 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2647 | 0.020 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 615 | 0.020 |
Why?
|
Substantia Nigra | 1 | 2011 | 353 | 0.020 |
Why?
|
Pentetic Acid | 1 | 2009 | 213 | 0.020 |
Why?
|
Bacteria | 1 | 2019 | 2114 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2187 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2575 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2029 | 0.020 |
Why?
|
Hand Strength | 1 | 2011 | 448 | 0.020 |
Why?
|
Illusions | 1 | 2008 | 60 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1671 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3605 | 0.020 |
Why?
|
Neuroradiography | 1 | 2008 | 70 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
Family Health | 1 | 2013 | 1282 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 1440 | 0.020 |
Why?
|
Afferent Pathways | 1 | 2009 | 302 | 0.020 |
Why?
|
Rats | 2 | 2016 | 24260 | 0.020 |
Why?
|
Databases, Factual | 1 | 2022 | 7729 | 0.020 |
Why?
|
Sus scrofa | 1 | 2009 | 437 | 0.020 |
Why?
|
Brain Death | 1 | 2011 | 348 | 0.020 |
Why?
|
Extrapyramidal Tracts | 1 | 2006 | 18 | 0.020 |
Why?
|
Touch | 1 | 2009 | 306 | 0.020 |
Why?
|
Extracellular Space | 1 | 2009 | 594 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6386 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2009 | 494 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29144 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2014 | 1534 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 25625 | 0.020 |
Why?
|
Internal Capsule | 1 | 2006 | 113 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5535 | 0.020 |
Why?
|
Actigraphy | 1 | 2009 | 488 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2011 | 752 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2297 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2005 | 126 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1107 | 0.020 |
Why?
|
Parahippocampal Gyrus | 1 | 2006 | 116 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2014 | 1444 | 0.020 |
Why?
|
Catheterization | 1 | 2010 | 1470 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15519 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2017 | 15295 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3200 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2902 | 0.020 |
Why?
|
Neural Inhibition | 1 | 2009 | 602 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
Pons | 1 | 2006 | 245 | 0.020 |
Why?
|
Basilar Artery | 1 | 2005 | 200 | 0.020 |
Why?
|
Neoplasms | 1 | 2013 | 21683 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2003 | 3479 | 0.020 |
Why?
|
Monitoring, Immunologic | 1 | 2004 | 100 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1953 | 0.010 |
Why?
|
Sensory Receptor Cells | 1 | 2009 | 492 | 0.010 |
Why?
|
Low Back Pain | 1 | 2012 | 956 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2005 | 264 | 0.010 |
Why?
|
Happiness | 1 | 2005 | 170 | 0.010 |
Why?
|
Phosphorous Acids | 1 | 2003 | 3 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2009 | 1767 | 0.010 |
Why?
|
Forearm | 1 | 2006 | 409 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 2003 | 162 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4328 | 0.010 |
Why?
|
Gravitation | 1 | 2003 | 82 | 0.010 |
Why?
|
Electrochemistry | 1 | 2003 | 145 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2009 | 1572 | 0.010 |
Why?
|
Pyrimidines | 1 | 2015 | 2942 | 0.010 |
Why?
|
Fixation, Ocular | 1 | 2004 | 251 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 741 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23403 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 497 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
Lactic Acid | 1 | 2007 | 1133 | 0.010 |
Why?
|
Survival | 1 | 2002 | 163 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9856 | 0.010 |
Why?
|
Posture | 1 | 2006 | 958 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1643 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7474 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1950 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 3002 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1856 | 0.010 |
Why?
|
Mitochondria | 1 | 2014 | 3520 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1442 | 0.010 |
Why?
|
Etoposide | 1 | 2002 | 641 | 0.010 |
Why?
|
Carboplatin | 1 | 2004 | 801 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12245 | 0.010 |
Why?
|
Hematoma | 1 | 2005 | 758 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8301 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10481 | 0.010 |
Why?
|
Arm | 1 | 2003 | 589 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 2005 | 726 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8554 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1133 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2726 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2003 | 976 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3251 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4669 | 0.010 |
Why?
|
Mice | 2 | 2016 | 81183 | 0.010 |
Why?
|
Anthropometry | 1 | 2003 | 1350 | 0.010 |
Why?
|
Muscles | 1 | 2003 | 1614 | 0.010 |
Why?
|
Child Development | 1 | 2010 | 2223 | 0.010 |
Why?
|
Postoperative Period | 1 | 2003 | 1842 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8340 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3493 | 0.010 |
Why?
|
Internet | 1 | 2009 | 3064 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 21827 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2005 | 9959 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2008 | 1917 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4933 | 0.010 |
Why?
|
Paclitaxel | 1 | 2004 | 1708 | 0.010 |
Why?
|
Cisplatin | 1 | 2002 | 1662 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 23338 | 0.010 |
Why?
|
Viral Load | 1 | 2005 | 3299 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10638 | 0.010 |
Why?
|
Software | 1 | 2009 | 4443 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2716 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12208 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2005 | 2576 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 3737 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12959 | 0.010 |
Why?
|
Patient Compliance | 1 | 2004 | 2684 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13408 | 0.010 |
Why?
|
Epilepsy | 1 | 2009 | 3310 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2004 | 3474 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2003 | 8642 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 10252 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2004 | 3057 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10397 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2005 | 5751 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9274 | 0.000 |
Why?
|
Hypertension | 1 | 2005 | 8480 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2006 | 11727 | 0.000 |
Why?
|